ADMA Biologics ADMA Total debt

Total debt at other companies

AbCellera Biologics Inc.ABCL

$135.62M-4.5%

Lifecore Biomedical, Inc.LFCR

$8.06M—

AnaptysBio, Inc.ANAB

$13.61K-99.9%

Absci CorporationABSI

$4M-37.2%

Avalo TherapeuticsAVTX

$242K-64.4%

Apogee Therapeutics, Inc.APGE

$8.05M-31.9%

FAQ

What is ADMA Biologics's total debt?

ADMA Biologics (ADMA) reported total debt of $203.89M in Q2 2026.

How has ADMA Biologics's total debt changed year-over-year?

ADMA Biologics's total debt increased by 1855.2% year-over-year, from $10.43M to $203.89M.

What is the long-term trend for ADMA Biologics's total debt?

Over 5 years (2020 to 2025), ADMA Biologics's total debt has grown at a -4.0% compound annual growth rate (CAGR), from $97.67M to $79.84M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.